Powered by
SHINE Technologies, LLC (SHINE), a pioneer in next-generation fusion-based technology, becomes North America’s largest producer of non-carrier added lutetium-177 (n.c.a. Lu-177) chloride, a cutting-edge radiopharmaceutical used in precision cancer treatment, with a Drug Master File (DMF) to the U.S. Food…
Initiative advances precision cancer medicine by bringing comprehensive genomic profiling and hereditary cancer tests to patients at the Mayo Clinic Comprehensive Cancer Center Exact Sciences, a leading provider of cancer screening and diagnostic tests, today announced the launch of an…
In today’s landscape, the importance of board diversity and inclusion is increasingly under the spotlight. On Wednesday, March 13, WiB and TEMPO Madison‘s Project Reach had the privilege of putting together a thought-provoking discussion where TEMPO’s experts shared invaluable insights…
As we celebrate Forward BIOLABS‘ fifth anniversary and its impact on the biohealth community, we must reflect on a remarkable journey of innovation and growth. From humble beginnings to becoming a cornerstone of Wisconsin’s biohealth community, Forward BIOLABS has consistently…
FOR IMMEDIATE RELEASE February 29, 2024 Following Wisconsin’s designation as a Regional Technology and Innovations Hub (Tech Hub) from the Economic Development Administration (EDA) last October, the Wisconsin Biohealth Tech Hub submitted its Phase 2 application seeking $75…